Objectives: Medication safety in community pharmacy have been increasingly focused in Japan as community pharmacy routinely handles with prescription of such high risk drugs as anticoagulation drug, anti-tumor drug and so on. Nationwide pharmaceutical near-miss reporting and learning system has been operated by the Japan Council for Quality Health Care (JQ) since 2009 aiming at enhancing medication safety in community pharmacy. Near-misses reported in 2015 were put on analysis for creating preventive knowledge. Methods: Near-miss which occurred or was identified in community pharmacy is routinely collected from registered community pharmacy on voluntary basis in the reporting system. JQ collects, tabulates data of those events and compiles annual report and monthly case report. On observation of the reports, several focused areas are identified and put on further analysis to withdraw lessons for prevention.
Results: The pharmaceutical near-miss reporting system collected 4,779 near-misses in 2015. The breakdown of collected near-misses revealed that 78.0% near-misses (3,727 cases) are those related to dispensing such as wrong quantity, wrong strength, wrong form of drug and so on. What was most highlighted was that increasing number of cases were related to clarification by pharmacist on questionable prescription issued by hospital/clinic. The government policy on medication to patients has been that prescription and dispensing are separately allocated to hospital/clinic and community pharmacy. Clarification on questionable prescription was stipulated in "Article 24 of Pharmacist Law" as a vital role of pharmacist. The near-miss related to clarification accounts for 21.8% (1,040 cases) of reported cases. It was revealed that patients' health conditions were possibly affected if dispensed along with original prescription in 64.6% (672 cases) near-misses among 1,040 near-misses related to clarification. Therefore, near-misses related to clarification were focused and put on in-depth analysis in terms of background human factors, the way to identify error on prescription, brand names of drug and so on. As a result, prescribed drugs are frequently deleted (26.0%, 270 cases) and/or replaced with correct drugs (34.8%, 362 cases) by adequate clarification which was triggered by identifying duplication of drugs on prescription sheet or inconsistency of latest prescription with past prescription records of individual patients filed in a pharmacy. Specifically, such drugs as anti-ulcer drugs and analgesics are frequently reported. Near-misses with failed clarification were later found questionable on the following reasons. i) Pharmacist reviewed dispensing record., ii) Family gave pharmacist question on the medication., iii) Patient visited pharmacy for the next dispensing. Therefore, it was suggested that confirmation of patient's name, current health condition, past side effect, patient's age and confirmation of pregnancy are effective for prevention.
Conclusion:
The nationwide pharmaceutical near-miss reporting system is now widely welcomed and utilized in Japanese pharmaceutical society, medical society and relevant societies. It is successful in a sense that it has been offering scientific data of near-misses such as those related on inquiry on questionable prescription. Reference Objectives: Clostridium difficile has surpassed other pathogens in causing healthcare-associated infections. Hospital-onset C. difficile is associated with patient morbidity including increased lengths of stay, readmissions and excess medical expenditures. Reported rates, as defined by the National Health and Safety Network, are unacceptably high. In 2016, the Mount Sinai Health System (MSHS) identified hospital-onset C. difficile infection (HO-CDI) as a leadership priority. In order to disseminate and implement best practices across a diverse health system, leadership partnered with infection prevention and capitalized on system-wide and local expertise, spearheaded data-driven decision-making, and provided frequent audit and feedback to system and local leadership and frontline providers.
1. Illustrate how an interdisciplinary team can collaborate to reduce in C. difficile in a health system 2. Identify specific interventions to reduce C. difficile infections.
Methods:
The MSHS implemented a four-pronged approach to reducing HO-CDI: diagnostic stewardship, enhanced environmental cleaning with audit and feedback, antibiotic stewardship, and a leadership-sponsored hand hygiene campaign. A diagnostic decision tree was rolled-out throughout the system via education of frontline providers, leveraging the electronic medical record, and clinical laboratory audits. Disinfection practices and audit and feedback of environmental disinfection using qualitative and quantitative methods were standardized. Antibiotic stewardship programs were reevaluated and prior authorization and audit feedback practices were coordinated. A system-wide leadership-sponsored hand hygiene campaign was launched moving hand hygiene compliance out of the purview of infection prevention to the frontline providers. Each of the above interventions was addressed at all of the system hospitals with local leadership determining the site-specific implementation plan for each hospital to accommodate differences in patient population, workflow, staffing, resources, and structural limitations. HO-CDI rates are regularly shared at the hospital and system levels via a quality dashboard. Results: The coordination and bundling of interventions contributed to a 43% decrease in HO-CDI for the MSHS between 2013 to 2016 (95% CI: 36% -49%, p-value: < 0.001). The system reduced HO-CDI from 7.23 per 10,000 patient-days in 2013 to 4.13 per 10,000 patient-days in 2016 (p < 0.001). Between 2013 and 2016, each individual hospital successfully decreased their HO-CDI rate, ranging from a 32% decrease to a 79% decrease. Conclusion: Decreasing patient harm, including hospital-acquired infections, is an urgent matter for hospitals and health systems. The Mount Sinai Health System implemented a four-pronged approach to decreasing CDI. System and local leadership prioritized reducing HO-CDI and found great success with leveraging internal expertise and rolling out a multidisciplinary harmonized process to reducing patient harm. Development of dashboards and a clinical governance structure facilitated both learning and collaboration. Despite diverse patient populations and individual institutional limitations, the elevated and intensive focus on decreasing patient harm allowed for a dramatic reduction in CDI. Future efforts will focus on long-term sustainability, as well using a similar approach for the reduction of other healthcare-associated infections. Objectives: Medication reconciliation is an effective way of reducing errors at transitions of care. Much of the focus in the UK has been on medicines reconciliation on admission to hospital, until national guidance, [1] a NHS England patient safety alert [2] and changes to the NHS England Standard Contract broadened this to primary care. The objective was to assess the completeness, timeliness and reconciliation in primary care of medicines information on hospital discharge summaries. Methods: Clinical Commissioning Groups (CCGs) across England were invited to participate in a collaborative project during January 2016 for patients discharged during the previous three months. CCG pharmacists identified patients retrospectively from GP prescribing systems and collected data using a standardised tool based on national standards, developed by a multidisciplinary group and validated through a series of pilots. Anonymised data were entered onto an excel spreadsheet by the CCG pharmacists and submitted electronically for collation and analysis. Results: 47 CCGs participated and submitted data for 1454 patients (3-404 per CCG). Key findings are summarised in the table. Although many discharge summaries were generated (89%) and transferred (72%) electronically, only 43% were received by the GP practice on the same day. Overall patient demographics were stated on most of the discharge summaries, except allergy status which was only documented in 75.8% of cases. Majority of the medication details were stated except formulation (60.3%) and instructions for ongoing use or supply (72.5%). Reason for initiation of new medicines was documented in half of the 79% where at least one new medicine was started. Apparent unintentional omissions of pre-admission medicines were noted for a third of the patients. Intentional changes Abstracts
